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BACKGROUND AND PURPOSE: The pathogenesis and characteristics of multiple DAVSs are not well-
known. The purpose of this study was to evaluate the angiographic and clinical characteristics of
patients with multiple DAVSs with an emphasis on the pathomechanism.
MATERIALS AND METHODS: One hundred seventy-nine patients with DAVS were reviewed. Patients
with 2 fistulas at anatomically separate sites were included. Multiple DAVSs were categorized into
synchronous (simultaneous multiplicity) or metachronous (temporal sequential development of multi-
plicity) types. The angiographic and clinical characteristics of these lesions were analyzed.
RESULTS: Fourteen patients were diagnosed with multiple DAVSs (7.8%; synchronous, n  7;
metachronous, n  7). Thirteen of the 14 patients showed CVR (93%, Borden type II/III). Multiple
DAVSs were frequently associated with dural sinus thrombosis (71.4%, n  10). Synchronous DAVSs
developed in association with an occluded sinus (n  5). De novo metachronous lesions developed in
association with thrombosis of a previously patent dural sinus (n 3) or reopening of an occluded sinus
(n  2). Multiplicity was associated with aggressive initial symptoms in 64.3% (n  9). The newly
developed lesions in the metachronous types were accompanied by hemorrhage (n  1), neurologic
deficit (n  1), worsening of the initial benign symptoms (n  2), and incidental detection (n  3). The
mean time interval between the initial diagnosis and de novo lesion detection was 31.3 29.8 months
(range, 12–92 months).
CONCLUSIONS: Multiplicity of DAVSs is associated with poor angiographic and clinical prognosis,
requiring an aggressive treatment and management strategy. Sinus thrombosis has a prominent role
in the pathomechanism of DAVSs.
ABBREVIATIONS: CS cavernous sinus; CVR cortical venous reflux; DAVS dural arteriovenous
shunt; MS  marginal sinus; SS  sigmoid sinus; SSS  superior sagittal sinus; TS  transverse
sinus
DAVS is a disease in which abnormal arteriovenous com-munications develop within the dura. These are dynamic
lesions and can show spontaneous healing or pattern changes
on follow-up DSA.1,2 DAVSs compose approximately 10% of
all intracranial vascular malformations.3 They are generally
considered to be acquired diseases in the adult as opposed to
other intracranial vascular malformations, but their patho-
mechanism in terms of lesion development and temporal
changes has not been clearly established. A wide variety of
factors, such as infections, surgery, postpartum status, and
various coagulopathies, may provide a conducive environ-
ment for disease development.1,4,5 Angiogenic growth factors
and sinus thrombosis associated with venous hypertension
have also been implicated in the pathogenesis of DAVS.4,6
Only a few articles with a small number of cases have been
reported concerning multiple DAVSs. Multiplicity of DAVSs
can be seen simultaneously, or a de novo lesionmay develop in
a temporal sequence.7-20 The angiographic and clinical char-
acteristics of these lesions need further elucidation, and an
investigation of the multiplicity of DAVSs may provide new
understanding in the pathogenesis and the pathomechanism
of this dynamic disease.
The purpose of this study was to analyze the angiographic
and clinical characteristics of multiple DAVSs with special in-
terest in the pathomechanism.
Materials and Methods
Patients
The patients were selected from a single institution data base consist-
ing of 194 cases diagnosed as or treated for intracranial DAVSs be-
tween January 2000 and February 2011. The data have been collected
prospectively since 1980 in a dedicated neurointerventional data base.
The diagnosis of DAVS was based on DSA findings. Patients without
DSA (n 15) were excluded from this study. The imaging findings of
DSA, CT, MR imaging, and medical records of 179 patients were
reviewed. Institutional review board approval was obtained for this
retrospective analysis with a waiver of informed consent.
Imaging and Clinical Analysis
The DSA images were investigated for multiplicity, location, CVR,
treatment method/result, and sinus patency. CVR was classified ac-
cording to the Borden classification: type I, drainage directly into the
dural venous sinuses or meningeal veins; type II, drainage into the
dural sinuses or meningeal veins but also with retrograde drainage
into the subarachnoid veins; and type III, drainage into the subarach-
noid veins without dural sinus or meningeal venous drainage.21
“Multiplicity” was defined as the occurrence of2 fistulas at anatom-
Received December 1, 2011; accepted after revision January 14, 2012.
From the Department of Radiology, Yonsei University College of Medicine, Seoul, Korea.
This work was supported by a grant from the Korea Healthcare Technology R&D Project,
Ministry for Health and Welfare Affairs, Republic of Korea (A085136).
Please address correspondence to Dong Joon Kim, MD, PhD, Department of Radiology,
Severance Hospital, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu,
Seoul 120-752, South Korea; e-mail: djkimmd@yuhs.ac
Indicates open access to non-subscribers at www.ajnr.org
http://dx.doi.org/10.3174/ajnr.A3054
IN
TERVEN
TIO
N
A
L
ORIGIN
AL
RESEARCH
AJNR Am J Neuroradiol 33:1691–95  October 2012  www.ajnr.org 1691
ically separate sites in 1 patient. Multiple DAVSs were categorized as
“synchronous” if the shunt occurred simultaneously in different du-
ral sinuses and “metachronous” if a de novo shunt developed at a
different location in a temporal sequence. Chronologic changes on
DSA in patients with metachronous DAVSs were analyzed. Brain CT
orMR imaging was evaluated for the presence of hemorrhage, venous
hypertension, and sinus thrombosis. Clinically, the patients were gen-
erally followed on a 2- to 3-month basis for a year and 6- to 12-month
intervals afterward. Imaging studies were performed during this fol-
low-up period in reference to the treatment results and whether
changes or deterioration of symptoms believed to be related to the
DAVS had occurred. The clinical characteristics of the patients, such
as sex, age, initial/follow-up symptoms, development of hemorrhage,
and long-term outcome were analyzed.
A board-certified neuroradiologist and neurologist (D.J.K. and
S.Y.H.) reviewed the angiographic and clinical findings in consensus.
Results
Fourteen of 179 patients were diagnosed as having multiple
DAVSs (7.8%) on DSA. Ages ranged from 1 to 68 years (mean
age, 45  19.7 years; male/female  9:5). The multiplicity of
the 14 patients was categorized as synchronous (n  7) or
metachronous (n  7) types. The mean duration of clinical
follow-up for the metachronous lesions was 66 months (17–
122 months).
Thirteen of the 14 patients with multiple DAVSs showed
CVR (93%, Borden type II / III) on the initial DSA. The loca-
tions of the synchronous types were CSMS, TSMS, SSS
 SS, SSS SS TS, SS TS, TS jugular bulb, and SS
frontal convexity, respectively (Table 1). The locations of the
metachronous types were SSS  TS (n  2), CS  SS, CS 
MS, TS torcular herophili, bilateral TS, and falcine sinus
torcular herophili, respectively (Table 2). Four of the 7 de
novo DAVSs showed CVR.
Angiographically, the multiple DAVSs were frequently as-
sociated with dural sinus thrombosis (71.4%, n  10). Syn-
chronous DAVS developed in association with a thrombosed
sinus in 5 of the 7 patients (71.4%). In the metachronous
types, 5 of the 7 de novo shunts developed in association with
thrombosis of a previously patent dural sinus (n 3; cases 9,
10, and 11) or reopening of an occluded dural sinus (Fig 1; n
2, cases 8 and 12). In terms of temporal development, sinus
thrombosis was verified on DSA before sequential de novo
lesion development in 3 patients (Fig 2; cases 8, 11, and 12).
Table 1: Clinical and angiographic characteristics of multiple synchronous DAVSs
Case
No.
Sex/Age
(yr) Initial Presentation Location
Borden
Type Sinus Patency Treatment/Result
1 F/53 Headache, tinnitus, chemosis CS, left II Occluded IPS TAE, TVE/Po
MS, right I Occluded MS TVE/Co
2 M/54 Gait disturbance SS, left II Occluded SS TVE/Co
SSS III Patent SSS TAE/Co
3 F/59 Aphasia, hemianopsia SS, left II Near-occluded TS, left TAE/Co
TS, right I Patent TS, right TAE/Po
4 M/42 Seizure SS, right II Isolated SS TVE/Co
Frontal convexity, left III TAE/Co
5 M/58 Hb TS, left II Patent TS TVE, Onyx/Co
Jugular bulb, left I Isolated sinus None
6 M/59 Exophthalmoses TS, right II Patent TS TAE, TVE/Co
MS, right I Patent MS TAE, TVE/Co
7 M/49 Right arm weakness, aphasia SSS II Patent SSS None
TS, right I Patent TS None
SS, right I Patent SS None
Note:—Co indicates complete occlusion; Hb, hemorrhage; IPS, inferior petrosal sinus; Po, partial occlusion; TAE, transarterial embolization; TVE, transvenous embolization.
Table 2: Clinical and angiographic characteristics of multiple metachronous DAVSs
Case
No
Sex/Age
(yr)
Initial Presentation (1)/
De Novo Lesion Presentation (2) Location
Borden
Type
Time Interval
(months) Sinus Patency Treatment/Result
8 F/68 1) Eyeball pain, ptosis CS, left II Occluded SS TAE/Co
2) Hb, delayed Hb SS, left II 17 Recanalized SS TAE, burr-hole/Co
9 F/56 1) Eyeball pain, pulsatile tinnitus CS, right I Occluded IPS after TVE TVE/Co
2) Pulsatile tinnitus MS, left I 17 Occluded IPS TVE/Co
10 M/17 1) Hb TS, right II Patent torcular TAE, TVE, GKS/Po
2) Aggravated headache Torcular II 50 Occluded torcular Onyx/Po
11 M/1 1) Developmental delay Falcine sinus II Patent torcular TAE/Co
2) Routine follow-up Torcular II 12 Occluded torcular TAE, Onyx/Co
12 M/28 1) Seizure SSS II Occluded TS TAE, TVE/Po
2) Right leg weakness (delayed Hb)a TS, left I 92 Recanalized TS TAE/Po
13 M/58 1) Gait disturbance, memory dysfunction SSS II Patent TS TAE, burr-hole/Co
2) Routine follow-up TS, right I 20 Patent TS TAE/Co
14 F/23 1) Bruit TS, both II/II Patent TS TAE, TVE/Po
2) Routine follow-up TS, left II 12 Stenotic TS, left TAE, TVE/Po
Note:—Co indicates complete occlusion; GKS, gamma knife surgery; Hb, hemorrhage; IPS, inferior petrosal sinus; Po, partial occlusion; TAE, transarterial embolization; TVE, transvenous
embolization.
a Intraventricular hemorrhage probably associated to partially treated lesions.
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Simultaneous sinus thrombosis and de novo lesion develop-
ment were discovered in 2 patients (cases 9 and 10). The other
2 metachronous lesions without sinus occlusion on angiogra-
phy showed partial thrombosis of the sinus on serial MR im-
ages (case 13) or stenosis of the sinus on serial angiograms
before de novo DAVS development (case 14).
For all lesions, the priority of treatment was placed on the
lesion with CVR. Complete occlusion of the shunt with CVR
was achieved by transarterial and/or transvenous emboliza-
tions in 5 patients with synchronous DAVSs. Partial occlusion
was achieved in 1 patient with CVR due to failure of the trans-
venous approach (case 1). One patient refused treatment (case
7). In the metachronous type, the initial lesions had been
treated by transarterial embolization (n 2), transvenous em-
bolization (n  1), and combined transarterial and trans-
venous embolizations (n 4), resulting in complete occlusion
in 4 patients. The de novo metachronous lesions were treated
by transarterial embolization (n 1), transvenous emboliza-
tion (n 1), transarterial and transvenous embolization (n
3), and Onyx (ev3, Irvine, California) embolization (n  2),
resulting in complete occlusion in 4 patients. Transvenousmi-
crocatheter manipulation had been performed in the sinus in
which the de novo lesion developed in 4 of the 7 patients (cases
9, 10, 12, and 14).
Overall, multiplicity of DAVSs was associated with aggres-
sive initial symptoms such as neurologic deficit, seizure, and
hemorrhage in 64.3% (9 of 14 patients). The synchronous type
was associated with aggressive initial symptoms in 71.4% (5 of
7 patients). Hemorrhagic presentation was seen in 1 patient
(case 5). In the metachronous type, initial hemorrhagic pre-
sentation was noted in 1 patient (case 10). Other initial symp-
toms were neurologic deficits (n  2), seizure (n  1), and
benign symptoms (n 3). The de novo lesions presented with
hemorrhage (n 1, case 8), neurologic deficit (n 1, case 12),
and worsening of the initial benign symptoms (n 2, cases 9
and 10). In case 8, delayed rehemorrhage occurred after trans-
arterial partial occlusion of the de novo lesion. The patient was
later cured by burr-hole puncture and sinus occlusion. In case
12, delayed hemorrhage was seen after detection of the de
novo lesion before treatment. The de novo lesions were inci-
dentally detected in the other 3 patients (cases 11, 13, and 14).
Two of these incidental de novo lesions showed CVR (cases 11
and 14). The mean time interval between the initial diagnosis
and de novo lesion detection was 31.3 29.8 months (range,
12–92 months).
Discussion
The results of our series reveal the aggressive angiographic and
clinical characteristics of multiple DAVSs and the prominent
role of sinus thrombosis in the various pathomechanisms of
DAVSs.
Thirteen of the 14 patients in our series showedCVRon the
initial DSA. This high incidence of CVR associatedwith amul-
tiplicity of DAVSs has been reported in other studies.7,15 It
may be due to venous hypertension enhanced by the multiple
DAVSs.14 There was no specific pattern of multiplicity in
terms of the location and the interval of the de novo shunt
development in our series.No specific sinuswas immune from
multiplicity, and there was no ipsilateral laterality as reported
by Kubo et al.18 Our angiographic analysis showed that the de
novo shunts had a tendency to occur in association with sinus
thrombosis, frequently at the edges of the thrombosed sinuses.
Prior history of transvenous embolization and the venousma-
nipulation of microcatheters and coils with activation of an-
Fig 1. Summary of the temporal sequence of de novo metachronous DAVS development in relation to sinus thrombosis.
AJNR Am J Neuroradiol 33:1691–95  October 2012  www.ajnr.org 1693
giogenetic factors have been implicated in the development of
de novo DAVSs through sinus thrombosis and venous ob-
struction in other series.19,20 In our series, 4 of the 7 meta-
chronous lesions were associated with prior intrasinus
manipulation.
The results of our study show the versatile feature of sinus
thrombosis in the pathomechanism of multiple DAVSs. Ve-
nous sinus thrombosis adjacent to the shunt was seen in 5 of
the synchronous cases, suggesting that either the sinus throm-
bosis induced the second shunt or the development of the
second shunt induced the sinus thrombosis. The temporal se-
quential findings of themetachronous cases suggest the role of
sinus thrombosis in the pathogenesis of this disease. Venous
thrombosis may be associated with the breakdown of autoreg-
ulation of dural microvascularization and activation of the
angiogenetic factor, resulting in DAVS development.22 Three
patients showed development of de novo DAVSs adjacent to
the occluded sinuses, which had been patent on the initial
study. The presence of thrombus on the angiogram/MR im-
ages in these patients before shunt development also suggests
the pathogenic potential of sinus thrombosis.
On the other hand, the development of a new shunt was
also associated with remote sinus thrombosis formation (Fig
2). The presence of a shunt with reflux into the adjacent sinus
may cause hemodynamic turbulencewith the normal draining
blood, leading to sinus thrombosis.14,22 Two patients showed
new DAVSs with recanalization of a previously occluded si-
nus. Although sinus thrombus may be the cause of new shunt
development, these cases show that the thrombus may also
regress or recanalize after the development of the DAVS,
which may be caused by the natural thrombolytic potency of
circulating blood. Not all cases in our series showed visible
sinus thrombus in relation to multiplicity. At least 2 cases
showed sinus patencywithout any stenosis or occlusion.How-
ever, pathologic studies have shown that despite the angio-
graphic evidence of sinus patency, thrombus can often be
identified histologically in DAVSs.23
In addition to its pathogenic potential, sinus thrombosis is
also known to be associated with spontaneous healing or pat-
tern conversion of DAVSs.2 Depending on the underlying ve-
nous topography, the upstream or downstream development
of sinus thrombus may alter the venous outflow pattern or
may be associated with spontaneous cure.
Although the DAVSs in children and youth (cases 10 and
11) may be congenital in origin compared with the acquired
lesions in adults, our experience shows that the pathomecha-
nism of de novo DAVS development involving thrombosis of
a previously patent dural sinus is similar in both children and
adults.
The multiplicity of DAVSs was associated with a high ratio
of aggressive initial symptoms, such as hemorrhage, neuro-
logic deficit, or seizure in our series (64.3%). The multiplicity
of lesions by itself may not be directly associated with aggres-
sive symptoms. However, these lesions were associated with a
high incidence of CVR in our series (13/14 cases). This is in
accordance with the previous reports claiming that multiple
lesions are related to a more aggressive clinical presentation
and entail a higher risk of hemorrhage.7 van Dijk et al15 re-
ported, on the basis of their 19 patients with synchronous
multipleDAVSs, that the percentage of hemorrhage at presen-
tation was 3 times higher in the multiple DAVS group. The
aggressive behavior at presentation is attributable to the high
Fig 2. Case 8. A, Initial left external carotid artery (ECA) lateral and left ICA anteroposterior (AP) delayed phase angiograms. Cavernous DAVS (large arrow) is seen with occlusion of the
left sigmoid sinus (small arrows). Transarterial embolization of the cavernous DAVS with polyvinyl alcohol particles was performed, resulting in complete occlusion. B, The patient presented
with hemorrhage 17 months later. Follow-up left ECA lateral and left ICA AP delayed phase angiograms show de novo DAVS development at the previously occluded left sigmoid sinus
(large arrow), with recanalization of this segment of the sinus. Upstream thrombosis of previously patent left proximal transverse sinus (small arrows) is seen, resulting in isolation of the
de novo shunt.
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rate of CVR.24 Also of interest is the relatively higher associa-
tion of the de novo lesions with hemorrhage compared with
the initial lesions in our metachronous group. Two of the 7 de
novo lesions were associated with hemorrhagic presentation
(n  1, case 8) or hemorrhage before treatment (n  1, case
12). The unstable dynamic changes of the venous flow pattern
in these de novo lesions in association with CVR may have
been a contributing factor for hemorrhage.
The high ratio of patients with synchronous andmetachro-
nous multiple DAVSs showing aggressive angiographic and
clinical patterns underscores the importance of aggressive
management for these patients. An important observation in
the metachronous group in our series is that despite the high
association of the de novo lesionswithCVR, 3 of 7 lesionswere
not associated with any change in subjective symptoms/signs
and were discovered on routine follow-up. Performing addi-
tional investigations in patients with DAVS who reveal a
change in symptoms has been generally accepted.2 However,
on the basis of our results, it may be prudent to perform peri-
odic angiographic follow-up studies, especially in those cases
with evidence of sinus thrombosis due to the risks of silent
aggressive metachronous lesion development. Noninvasive
studies such as time-resolvedMRA imaging may be a safe and
effective technique for follow-up.25
Conclusions
Multiplicity of DAVSs is associated with poor angiographic
and clinical prognosis requiring an aggressive treatment and
management strategy. Sinus thrombosis has a prominent role
in both the cause and the consequence of DAVSs.
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